Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen

Vaccine

Volumn 17, Issue 4, 1999, Pages 340-344

  Gu, Mi Li ^a   Leppla, Stephen H ^b   Klinman, Dennis M ^a  

^a Center for Biologics   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Anthrax; DNA vaccine; Toxin

Indexed keywords

ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; PLASMID DNA;

ADOLESCENT; ANIMAL CELL; ANTHRAX; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMORAL IMMUNITY; IMMUNITY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; DNA; FEMALE; GENETIC CODE; INTERFERON TYPE II; INTERLEUKIN-4; LETHAL DOSE 50; MICE; MICE, INBRED BALB C; PLASMIDS; VACCINATION;

EID: 0344222167     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00210-2     Document Type: Article

References (27)

1. Leppla SH, Ivins BE, Ezzell JWE, Anthrax toxin. In: L, Leive, editor. Microbiology. Washington, DC: American Society of Microbiology, 1985:62-66.
2. Leppla S, Anthrax Toxins. In: J Moss, B Iglewski, M Vaughan, A, Tu, editors. Toxins and Virulence Factors in Disease. Bacterial Handbook of Natural Toxins. New York, NY: Marcel Dekker, Inc. 1995:543-572.
3. Thorne CB, Bacilus anthracis. In: AB Soneshein, JA Hoch, R Losick, editors. Bacillus subtilin and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. Washington, DC; American Society for Microbiology, 1993:113-124.
4. Uchida A., Hashimoto K., Terakado N. Virulence and immunogencity in experimental animals of Bacillus anthracis strains harboring or lacking 110 MDa and 60 MDa plasmids. J Gen Microbiol. 132:1986;557-559.
5. Leppla S.H. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA. 79:1982;3162-3166.
6. Klimpel K.R., Arora N., Leppla S.H. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence with is required for lethal toxin activity. Mol Microbiol. 13:1994;1093-1100.
7. Turnbull PCB, Quinn CP, Hewson R, Stockbridge MC, Melling J. Proceedings of the International Workshop on Anthrax. Ed. Turnbull JCB. Protection conferred by microbially-supplemented UK and purified PA vaccines. 1990;68:89-91.
8. Ivins B.E., Welkos S.L., Liffle S.F., Crumrine M.H., Nelson G.O. Immunization against anthrax with Bacilus anthracis protective antigen combined with adjuvants. Infect Immun. 60:1992;662-668.
9. Ivins B.E., Fellows P., Pitt L., Estep J., Farchaus J., Friedlander A., Gibbs P. Experimental anthrax vaccines: Efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine. 13:1995;1779-1784.
10. Brachman P.S., Gold H., Plotkin S.A., Fekety F.R., Werrin M., Ingraham N.R. Field evaluation of a human anthrax vaccine. Am J Publ Health. 52:1962;632-645.
11. Singh Y., Klimpel K.R., Arora N., Sharma M., Leppla S.H. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor. J Biol Chem. 269:1994;29039-29046.
12. Coulson N.M., Fulop M., Titball R.W. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge. Vaccine. 12:1994;1395-1401.
13. Pezard C., Weber M., Sirard J.C., Berche P., Mock M. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun. 63:1995;1369-1372.
14. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkoski S.H., Deck R.R., DeWitt C.M., Friedman A. Heterologous protection against influenza by injection of DNA encoding a viral protein [see comments]. Science. 259:1993;1745-1749.
15. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., Sato A., Boyer J., Williams W.V., Weiner D.B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;4156-4160.
16. Wolff J.A., Malone R.W., Williams P., Chong W., Ascadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
17. Manthorpe M., Cornefert J.F., Hartikka J., Felgner J., Rundell A., Margalith M., Dwarki V. Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Hum Gene Ther. 4:1993;419-431.
18. Welkos S.L., Lowe J.R., Eden-McCutchan F., Vodkin M., Leppla S.H., Schmidt J.J. Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene. 69:1988;287-300.
19. Gordon V.M., Klimpel K.R., Arora N., Henderson M.A., Leppla S.H. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun. 63:1995;82-87.
20. Mor G., Klinman D.M., Shapiro S., Hagiwara E., Sedegah M., Norman J.A., Hoffman S.L., Steinberg A.D. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol. 155:1995;2039-2046.
21. Leppla SH. Production and purification of anthrax toxin. In: S Harshman, editor. Methods in Enzymology. Orlando, FL: Academic Press, Inc. 1988:103-116.
22. Shirai A., Conover J., Klinman D.M. Increased activation and altered ratio of IFNg: IL-4 secreting cells in MRL/lpr mice. Autoimmunity. 21:1995;107-116.
23. Klinman DM, Nutman TB. ELIspot assay to detect cytokine-secreting murine and human cells. Current protocols in immunology. Eds Coligan JE, Krvisbeek AM, Marguilies DH, Shevach EM, Strober W. 1994;7.
24. Little S.F., Leppla S.H., Cora E. Production and characterization of monoclonal antibodies to the protective antigen of Bacillus anthracis toxin. Infect Immun. 56:1988;1807-1813.
25. Ezzell J.W., Ivins B.E., Leppla S.H. Immunoelectophortic analysis, toxicity and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect Immun. 3:1984;761-767.
26. Turnbull P.C. Anthrax vaccines: Past, present and future. Vaccine. 9:1991;533-539.
27. Shlyakov E.N., Rubenstein E. Human live anthrax vaccine in the former USSR. V IFNγ acc. 12:1994;727-730.